Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd Edition

Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd Edition

Publisher

Cardiotext

Language

‎English

Edition

3th

Format

Publisher PDF

ISBN-13

9781935395522

$23.00

5/5
Description

Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd Edition

Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd Edition” offers immediate access to current information on the use of approved cardiovascular drugs for both adults and children, underpinned by the scientific rationale for their clinical application.

Condensing the editors’ esteemed and comprehensive textbook, “Cardiovascular Pharmacotherapeutics, 3rd Edition,” this treatment-focused abridgement provides essential details, including indications, contraindications, dosages, side effects, pharmacokinetics, and adverse reactions for all approved cardiovascular medications, encompassing the latest therapeutic agents.

Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd Edition also delivers insightful guidelines for therapeutic strategies, clear tables and charts summarizing critical clinical choices, and useful appendices reviewing the approved uses and pharmacologic characteristics of these agents.

Moreover, it addresses the management of patients on multi-drug regimens and delves into drug-drug interactions and alternative medicine approaches to cardiovascular disease.

Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd Edition brings a valuable companion website, www.cvpct3.com, offering updates, links to recent studies, and insights into newly FDA-approved cardiovascular drugs, fostering direct communication with the authors for related inquiries.

This abridged version selectively encompasses vital content from the hardcover Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd Edition while maintaining its clinical relevance and accessibility for healthcare professionals and students alike.

 

Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd Edition

Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd Edition

1.2.Key Features

The key features of the book “Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd Edition” are as follows:

  1. Comprehensive Coverage: Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd Edition provides current and comprehensive information on the use of all approved cardiovascular drugs for both adults and children, ensuring a broad and thorough understanding of pharmacotherapeutic options.
  2. Scientific Rationale: Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd Edition includes the scientific rationale behind the clinical use of cardiovascular drugs, offering readers valuable insights into the mechanisms of action and therapeutic principles.
  3. Detailed Drug Information: For each approved cardiovascular drug, the book offers information on indications, contraindications, dosages, side effects, pharmacokinetics, and adverse reactions, empowering healthcare professionals to make informed prescribing decisions.
  4. Guidelines for Therapeutic Strategies: The book provides rationales and usage guidelines for therapeutic strategies, aiding in the development of effective treatment plans.
  5. Summarizing Tables and Charts: Abundant tables and charts are included to summarize important clinical choices, making it easy for readers to access and apply key information.
  6. Useful Appendices: Handy appendices review approved uses of cardiovascular agents and their pharmacologic characteristics, enhancing reference utility.
  7. Multi-Drug Regimen Considerations: Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd Edition addresses considerations for managing patients on multi-drug regimens, helping clinicians navigate complex treatment scenarios.
  8. Drug-Drug Interactions: Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd Edition offers details on drug-drug interactions, crucial for avoiding potential complications arising from concurrent medication use.
  9. Alternative Medicine Insights: Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd Edition provides updated information on alternative medicine approaches to cardiovascular disease, offering a holistic perspective on patient care.
  10. Companion Website: With an accompanying website, readers gain access to periodic updates for each chapter, links to recent studies, information on newly FDA-approved cardiovascular drugs, and the opportunity to communicate directly with the authors for inquiries related to cardiovascular drug use.

 

Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd Edition

Cardiovascular Pharmacotherapeutics Abridged and Updated

1.3. About Writer

William H. Frishman and Domenic A. Sica are esteemed figures in the realm of cardiovascular medicine and pharmacology.

Dr. William H. Frishman, a distinguished physician and educator, has held prominent positions in academic medicine, including serving as a Chairman of Medicine.

He is widely recognized for his research contributions in areas such as hypertension, heart failure, and cardiovascular pharmacology.

Dr. Domenic A. Sica, a renowned clinical pharmacologist and hypertension specialist, has made significant strides in the understanding and management of hypertension and related cardiovascular conditions.

His work encompasses clinical trials, research, and publications that have advanced the field of cardiovascular medicine and pharmacotherapy.

Both editors have played pivotal roles in educating healthcare professionals and shaping clinical practice guidelines in the field of cardiovascular medicine, earning them recognition and respect among their peers.

Their collaborative efforts have resulted in authoritative texts that serve as essential resources for healthcare practitioners and researchers in the ever-evolving field of cardiovascular pharmacotherapeutics.

 

Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd Edition

Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd Edition

Summary

Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd Edition,” edited by William H. Frishman and Domenic A. Sica, is a comprehensive and up-to-date guide to the use of approved cardiovascular drugs for both adults and children.

Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd Edition distils the editors’ extensive textbook into a practical reference, providing essential details on indications, dosages, side effects, pharmacokinetics, and adverse reactions for all approved cardiovascular medications, including the newest therapeutic agents.

Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd Edition offers therapeutic strategies and guidelines, clear tables and charts for quick reference, and useful appendices summarizing approved uses and pharmacologic characteristics.

The book also addresses complex scenarios like multi-drug regimens and drug-drug interactions while exploring alternative medicine approaches to cardiovascular disease.

With an accompanying website for updates and direct author communication, Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd Edition is an invaluable resource for healthcare professionals, offering essential insights into the rapidly evolving field of cardiovascular pharmacotherapy.

 

 

Make sure that you are buying e-books from trustworthy sources. With over a decade of experience in the e-book industry, the Medbook1.com website is a reliable option for your purchase.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Cardiovascular Pharmacotherapeutics Abridged and Updated 3rd Edition”

Your email address will not be published. Required fields are marked *